From: Pediatric hospital admissions in Indigenous children: a population-based study in remote Australia
 | Conditions (ICD Code) | Frequency of admissions | Percentage of total |
---|---|---|---|
Top Primary Reasons for Presentation | |||
 Lower respiratory tract infection |  | 86 | 27.4 |
 | Lower respiratory tract infection (J22) | 74 |  |
 | Pneumonia (J18.9) | 10 |  |
 | Bronchiolitis (J21.9) | 2 |  |
 Gastroenteritis |  | 71 | 22.7 |
 | Infectious gastroenteritis (A09.9) | 68 |  |
 | Vomiting (R11) | 3 |  |
 Upper respiratory tract infection |  | 36 | 11.4 |
 | Otitis media (H66.3, H66.9, H70.019, H73.1) | 15 |  |
 | Upper respiratory tract infection (J06.9) | 14 |  |
 | Croup (J05.0) | 4 |  |
 | Tonsillitis (J03.9, J35) | 1 |  |
 | Pharyngitis (J02.9) | 1 |  |
 | Epiglottitis (J05.1) | 1 |  |
 Injury | Traumatic brain injury (S06.01), head injury (S09.9), fractured femur (S27.0), dislocated elbow (S53.10), finger injury (S69.7), soft tissue injury, hip (S76.7), superficial injury of leg/ft (S80.84, S90.82, S91.3), traumatic amputation of leg (T13.6), animal bite (dog or snake) (T14.1), foreign body (T16), corrosive burn (T24.0, T30.0), poison ingestion (T38.3) | 23 | 7.0 |
 Skin infection |  | 18 | 5.6 |
 | Impetigo (L01.0) | 1 |  |
 | Cutaneous abscess, furuncle, carbuncle (L02.0–.9) | 7 |  |
 | Cellulitis (L03.9) | 6 |  |
 | Skin sore (L98.9) | 3 |  |
 | Lymphadenitis (L04.3) | 1 |  |
 Failure to thrive | (R62.8) | 17 | 5.4 |
 Genitourinary |  | 14 | 4.4 |
 | Urinary tract infection (N39.0) | 12 |  |
 | Post infectious complications (N05.9, N12) | 2 |  |
 Asthma | (J45.9) | 10 | 3.2 |
Subtotal admission reasons | Â | 275 | 87.1 |
 Other |  | 39 | 12.9 |
Total Admission reasons | Â | 314 | 100 |
Top Comorbidities at Presentation | |||
 Upper respiratory tract infection | H66.3, H66.9, J03.9, J05.0, J06.9 | 20 | 18.1 |
 Failure to thrive | R62.8 | 15 | 13.6 |
 Anaemia | D64.9 | 14 | 12.7 |
 Gastroenteritis | A07.1, A08.0, A09.9, E87.2 (acidosis) | 8 | 7.3 |
 Asthma | J45.9 | 4 | 3.6 |
 Fever, unspecified | R50.9 | 4 | 3.6 |
Subtotal comorbidities | Â | 65 | 58.9 |
 Other |  | 45 | 41.1 |
Total comorbidities | Â | 110 | 100 |